Last reviewed · How we verify

maintenance of anaesthesia with sevoflurane

Centre Hospitalier Universitaire Dijon · FDA-approved active Small molecule Quality 5/100

maintenance of anaesthesia with sevoflurane is a Small molecule drug developed by Centre Hospitalier Universitaire Dijon. It is currently FDA-approved.

At a glance

Generic namemaintenance of anaesthesia with sevoflurane
SponsorCentre Hospitalier Universitaire Dijon
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about maintenance of anaesthesia with sevoflurane

What is maintenance of anaesthesia with sevoflurane?

maintenance of anaesthesia with sevoflurane is a Small molecule drug developed by Centre Hospitalier Universitaire Dijon.

Who makes maintenance of anaesthesia with sevoflurane?

maintenance of anaesthesia with sevoflurane is developed and marketed by Centre Hospitalier Universitaire Dijon (see full Centre Hospitalier Universitaire Dijon pipeline at /company/centre-hospitalier-universitaire-dijon).

What development phase is maintenance of anaesthesia with sevoflurane in?

maintenance of anaesthesia with sevoflurane is FDA-approved (marketed).

Related